Focus research 2022 MICROPANC team
Research coordinated by Dr Corinne Bousquet and Prof Cindy Neuzillet (Institut Curie – Saint Cloud) based on bioinformatics and immunohistochemical analyses on a large number of patients with pancreatic adenocarcinoma has identified molecular signatures associated with different original subpopulations of cancer-associated fibroblasts, two of which are prognostic and help in defining specific subtypes of immune, anti-tumor or immuno-suppressive stroma. Identifying these stromal signatures could enable better molecular stratification of tumors and hasten personalized medicine in this cancer, which remains a therapeutic failure. Read the article
To find out more about the IUCT-Oncopole and CRCT-Oncopole research focuses, please click here.
![logo_crct_v-1 Centre de Recherches en Cancérologie de Toulouse](https://www.crct-inserm.fr/wp-content/uploads/2021/03/logo_crct_v-1.png)
Centre de Recherches contre le Cancer de Toulouse (Oncopole)
Toulouse - FR
Nous contacter
+33 5 82 74 15 75
Nous rejoindre ?
![InsermSeul_Rvb__noir](https://www.crct-inserm.fr/wp-content/uploads/2022/01/InsermSeul_Rvb__noir.png)
![Logo-CNRS](https://www.crct-inserm.fr/wp-content/uploads/2021/08/Logo-CNRS.png)
![logo-ut3](https://www.crct-inserm.fr/wp-content/uploads/2023/03/logo-ut3.jpg)